Case | 3 December 2025
Setterwalls has advised Integrum AB in connection with a rights issue of approximately SEK 42.7 million
Setterwalls has advised Integrum AB in connection with an oversubscribed rights issue of shares that will provide Integrum with proceeds of approximately SEK 42.7 million before deduction of transaction costs.
Integrum AB is a medical technology company which develop and market a system for bone-anchored prostheses. Integrum’s class B shares are listed on Nasdaq First North Growth Market.
Setterwalls has acted as legal advisor to Integrum throughout the transaction process.
Contact:
Practice areas:
